Progress in the Research and Development of Anti-COVID-19 Drugs

Frontiers in Public Health

article

Lianzhou Huang¹  Weisheng Luo¹  Feng Li¹  Yuan Wang¹  Yiliang Wang¹  Yifei Wang¹ 

[1]Guangzhou Jinan Biomedicine Research and Development Center, College of Life Science and Technology, Jinan University

关键词: COVID-19;    SARS-CoV-2;    anti-COVID-19 drugs;    remdesivir;    lopinavir/ritonavir;    chloroquine;    plasma therapy;    glucocorticoid;   

DOI  :  10.3389/fpubh.2020.00365

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

The outbreaks of COVID-19 due to SARS-CoV-2 has caused serious physical and psychological damage to global human health. COVID-19 spread rapidly around the world in a short time. Confronted with such a highly infectious respiratory disease, the research and development of anti-COVID-19 drugs became an urgent work due to the lack of specific drugs for the treatment of COVID-19. Nevertheless, several existing drugs are available to relieve the clinical symptoms of COVID-19. We reviewed information on selected anti-SARS-CoV-2 candidate therapeutic agents published until June 2, 2020. We also discussed the strategies of the development of anti-COVID-19 drugs in the future. Our review provides a novel insight into the future development of a safer, efficient, and toxic-less anti-COVID-19 drug.

【 授权许可】

CC BY